One could argue that balneotherapy and mud therapy would have not lasted 2,000 years or so if they were not effective. No doubt a long history cannot be taken per se as scientific proof of efficacy. Some empiricism is still present in the field: the concept of spa itself is quite confounding, whereas spring waters are used for leisure purposes but also for non-acute patient therapy and late phases of clinical recovery. These confounding elements ultimately feed the opinion of those who aprioristically reject any potential beneficial effect of balneotherapy: instead, it should at least generate questions that deserve scientific answers. Clinical practices sequentially integrating pharmacological therapy with those natural principles for which a sufficient scientific demonstration is available, would probably cut the costs of public health, generating widespread advantages for the community. Recently, it has become evident that mineral waters may have intrinsic pharmacological properties. Of the numerous salts dissolved in thermal waters that might show pharmacological properties, for certain hydrogen sulfide (HzS)contained in sulfurous waters is the one that has obtained greater scientific attention, to which should be added the extensive scientific effort recently dedicated to HzS as a cellular gasotransmitter, independently from its natural sources. Dermatology and cosmetics are among the most studied applications of sulfurous waters, around which, however, some empiricism still confounds opinions: we therefore considered that a state-of-the-art focus on this topic might be timely and useful for future studies.
generating enzymes were studied in detail starting 30 years ago (I). Since then it has become evident that H 2S plays several other biological roles and functions involving neurological, cardiovascular, inflammatory and cancer diseases, which is no surprise, as H 2S is endogenously produced in most cells. Endogenous H 2S production is dependent on the complex of catabolic pathways of the sulfured amino acids and of glutathione reduction (GSH), and is strictly related to the control of the redox state of the cell. In particular, HoS is made by pyridoxal-phosphatedependent enzymes, including cystathionine-c-lyase (CGL, CSE), cystathionine-B-synthase (CBS) and 3-mercaptopyruvate sulfurtransferase (3-MST), during cysteine metabolism (1, 3). The putative quantification of the exact free and bioavailable sulfide levels in blood and tissues is probably from 50 to 150 11M; however, substantial differences in the absolute values have been reported. There are relevant differences in the methods and protocols used to quantify sulfuric acid and, in general, a number of sulfurous molecules acting as H 2S donors have been described (3) .
The anti-inflammatory properties of H 2S-rich waters on the skin have been known for centuries (4) , however, its molecular mechanisms are just starting to be understood, with growing attention to keratinocytes. The specific interest for skin derives from its potentially simple translation to patient care. This review focuses on the role of H 2S on skin in general and keratinocytes in particular, as a framework for the topical complementary treatment of specific skin diseases with H 2S/sulfurous waters.
Sulfurs in skin therapy
Most of the scientific literature on H 2S effects on cell viability, proliferation, activation, cytokine secretion and adhesion, refers to macrophages, granulocytes, fibroblasts, smooth muscle cells, myoblasts, cardiomyocytes, neuroblastoma cells, neurons, astrocytes, hepatocytes, endothelial cells, lymphocytes, intestinal epithelial and colon cancer cells (3) . As far as skin is concerned, sulfurs are able to penetrate the skin and a sulfur-rich balneotherapy, known to be effective in the treatment of psoriasis (5) , may be useful also in other T-cell-mediated autoimmune diseases of the skin.
Sulfur has a long history of topical use: hydrogen sulfide is present in a variety of skin care products, including soaps and cleansers (6) , and is used to reduce dandruff and decrease scalp scaling and dryness (7) . It has recognized fungicidal, bactericidal and antipruritic properties, and therefore it is used for the therapy of mite infestations in animals. Sulfur was even proposed as an antidote for acute exposure to radioactive material (8) . Indeed, it has been demonstrated that sulfurs favor wound healing, acts as a keratolytic agent and can induce various histological modifications in the skin (including hyperkeratosis, acanthosis, and dilation of dermal vessels).
Cytokines in skin inflammatory diseases
Psoriasis is now considered a genetically programmed, immune-mediated, skin-specific inflammatory disease, in which intralesional T lymphocytes trigger keratinocytes to proliferate and perpetuate the disease process (9) . Epidermal T cells are mainly CD8+, whereas dermal T lymphocytes are a mixture of CD4~and CD8~cells, with a CD4p redominance ( I0, II). Recent studies on the cellular pathogenesis of psoriasis revealed the involvement of specific classes of CD4+ T lymphocytes. In particular, it has been demonstrated that the Th 17/ Th 1 and Th 17/Treg ratios strongly change in psoriasis, with a predominant accumulation ofThl7 cells and reduction ofTreg.
In psoriatic plaque, the presence of Th l-type cytokines, including interferon (INF)-g, interlukin (IL)-2 and tumour necrosis factor (TNF)-a has been demonstrated (9) . Relevant cytokines produced by the keratinocytes of psoriatic lesions, such as IL-6 and IL-8, have been shown to induce keratinocyte proliferation (11). The more recently described IL-15, IL-17, IL-19, IL-20, IL-22 and IL-23, that also are found in psoriatic lesions and which also influence keratinocyte proliferation, are mainly produced by cells of hematopoietic origin such as dendritic (DC), macrophages, lymphocytes and granulocytes (12) . (11, 12) in several inflammatory skin pathologies including acanthosis, atopic dermatitis, cutaneous lupus erythematosus (13) . Increased IL-17 and IL-22 expression levels have been found in psoriatic lesions and epidermal hyperplasia (14, 15) ; both IL-17 and IL-22 have been shown to induce keratinocyte gene expression of antimicrobial~-defensins S100A8 and S I00A9, all up-regulated in psoriatic lesions (11, 15) . IL-8 released by keratinocytes has been shown to be induced by IL-17 via extracellular-signal-regulated kinase (ERK) activation (11, 16, 17) . Released IL-8, vascular endothelial growth factor (VEGF), and TNF -u promote neoangiogenesis, neutrophil and lymphocyte extravasation, perpetuating skin inflammation and dermal infiltration ofinflammatory cells.
Studies on the role of interleukins secreted by Thl7 cells (IL-17 and IL-22) revealed a complex interaction between T cells and keratinocytes
Another relevant pathogenic factor that must be considered in skin inflammatory pathologies is hypoxia, which impairs would healing and mediates dermic injury in various diseases, such as pressure, diabetic and venous ulcers (18) . Hypoxia mediates dermic injury by promoting the expression of important pro-inflammatory mediators as prostaglandins, that are synthesized through the activation of keratinocyte cyclooxygenases (19) .
In summary, a rationale therapeutic approach to inflammatory skin pathologies should limit activation, cytokine secretion and proliferation of keratinocytes and immune cells, in particular CD4+ and CD8+ lymphocytes.
H 2S and inflammation
It is now becoming evident that HzS exerts nonunivocal effects on inflammation. For example, it has been reported that administration of NaHS, a fast releasing HzS donor, induces an inflammatory reaction in liver and lung, and the extravasation of leukocytes in the lung (3).
On the contrary, several data support antiinflammatory effects of sulfurs: their ability to inhibit leukocyte adhesion to gastric mucosal blood vessels (3); their scavenger activity for proinflammatory oxidants (3, 20) ; their attenuation of lipopolysaccharide-induced formation of inflammatory mediators in macrophages (21); their inhibition of IL-6 secretion from fibroblasts in the synovial membrane of rheumatoid arthritis patients (22) .
Sulfurous spa waters are known for their antiinflammatory properties. Different waters (most of which contain sulfurs in various combinations with halogens or other ions) exert known beneficial effects on mucosal surfaces ofthe upper respiratory airways, and are normally administered by inhalation or aerosol (4, 23, 24) , restoring mucociliary clearance, physiological drainage and micro-environment of the upper airways and the Eustachian tubae (4). The molecular pathways underlying the role of hydrogen sulfide in inflammatory processes have therefore been a research challenge for balneotherapy for many years. It has been known for more than two decades that sulfur thermal waters have inhibitory effects on the proliferative response of T cells (25) . In a pioneering study, Valitutti et al. analyzed in vitro the phenotype and proliferation of peripheral blood mononuclear cells (PBMC) from ten patients treated with a 14-day cycle of inhalatory therapy for upper respiratory disorders and six patients taking mud therapy for osteoarticular diseases. Although inhalatory or mud therapy did not induce alterations in lymphoid subset distribution (as defined by CD2, CD3, CD4, CD8, CDl9 surface antigen expression), PBMC were highly sensitive to sulfur-enriched water in in vitro assays. The anti-proliferative effects of sulfurs were dose-dependent and more evident on anti-CD3, rather than PHA, stimulation. Moreover, Valitutti and coworkers hypothesized that the inhibitory effects of low dose sulfurs on lymphocyte proliferation was Thl-memory-restricted because exogenous IL-2 and/or INF-y were able to revert it. Much more recently, we studied the effects of hydrogen sulfide on human lymphocyte subset viability, proliferation and cytokine secretion (26) . Hydrogen sulfide induced a caspase-independent cell death ofhuman lymphocytes, with differential effects among lymphocyte subsets: CD8+ T lymphocytes and NK cells were far more sensitive to the toxic effects of sulfides than CD4+T cells. However, while high doses ofNaHS (2 mM) killed more than 80% of T cells, a residual significant fraction (50%) of NK still survived. Both surviving CD4 and CD8 T cells showed a decreased proliferative capacity in response to PHA and IL-2. Moreover, NaHS-surviving NK cells showed a decreased spontaneous cytotoxicity against tumor target cells and neither CD8 nor CD4 T cells secreted significant levels of IL-2 during activation. As previously reported, monocytes were resistant to sulfurs (26) while caspase-dependent neutrophil cell death is delayed by NaHS via p38 activation (27) .
H 2S and the cytokine secretion ofkeratinocytes
The exact role of H 2S in inflammation is controversial since both pro-and anti-inflammatory effects have been documented. However, the role of sulfurs on keratinocyte activation and inflammatory cytokine secretion is emerging.
Recently, it was reported that hydrogen sulfide can protect keratinocytes against chemical hypoxia-induced inflammatory response. Cobalt chloride (CoCI 2 ) , a well-known mimetic agent of hypoxia/ischemia, induces oxidative stress and inflammation. NaHS inhibits the inflammatory response of keratinocytes to cobalt chloride exposure. In particular, it has been demonstrated that NaHS significantly attenuates CoCl 2 -stimulated interleukin IL-6, IL-8 and IL-l p secretions from human keratinocyte-derived HaCaT cells (28) . Yang et al. speculated that NaHS could act by promoting elimination of ROS produced during hypoxia. Although a definitive in vivo demonstration is lacking, it has been shown that NaHS is able to eliminate superoxide anions and HP2 both by direct interaction (3) and, indirectly, via the potent endogenous antioxidant scavenger GSH (1, 3) . The anti-inflammatory signaling of sulfuric acid on skin can be also obtained by the inhibition of cytokine secretion by other cell types (such as macrophages, fibroblasts, endothelial cells), that playa role in the architectural changes of skin structure in psoriasis and other immune-based diseases. In particular, H 2S has been shown to attenuate lipopolysaccharideinduced formation of inflammatory mediators in macrophages and vascular endothelial cells (21) and, in addition, it also inhibits IL-6 secretion from the fibroblasts of the synovial membrane in rheumatoid arthritis patients (22) . Cytokines highly expressed by keratinocytes ofpsoriatic skin, such as IL-6 and IL-8, have been shown to induce keratinocyte proliferation and promote the recruitment of both neutrophils and T lymphocytes, thus greatly contributing to the pathophysiology of psoriasis (11). Recently, we have demonstrated both in vitro and in vivo that hydrogen sulfide not only reduces basal expression and secretion of IL-8, but also interferes with IL-17 and IL-22-induced IL-8 production by impairing ERK phosphorylation levels (11).
As far as the mechanism by which NaHS may impair ERK phosphorylation on keratinocytes, we observed that (29) hydrogen sulfide rapidly down-regulates phospho-ERKs levels by blocking MAPK kinases (MEK)-1I2 activation. Moving upstream along the MAPK signalling axis, we also demonstrated that NaHS signalling converges to serine/threonine protein phosphatases-l and 2A, that are known to activate the Raf/MEK/ERK pathway by inducing the dephosphorylation of Raf-l at ser 259 (an inhibitory phosphorylation site). Very recently, Merighi et al. reported that sulfurs may reduce VEGF secretion of human skin-derived keratinocyte cell lines (NCTC). The mechanism by which NaHS impairs VEGF transcription and protein secretion involves NO production (30) . In particular, these Authors demonstrated that NaHS, by activating the classical membrane phospholipid breakdown singaIling pathway, generated an Akt-dependent induction of inducible nitric oxide synthase (iNOS) expression followed by NO production. These increased levels ofNO, in tum, reduced the activation levels of the MAPK signaling pathway, preventing VEGF transcription in an ERK-II2-dependent way.
H 2S and keratinocyte growth
Human and mouse keratinocytes express a6p4 (laminin-5 receptor) integrin that contributes to their anchorage to the basal membrane in situ. Moreover, demonstrated the H 2S at micromolar a6p4 promotes keratinocyte migration and activates signaling pathways that are synergistic with those of growth factor receptors (31) . More in general, a6p4 is necessary for tumor cell invasion, cooperates with c-met in the transformation of rodent fibroblasts and is necessary to maintain the tumorigenic phenotype of carcinoma cells. Recently, we demonstrated that NaHS is able to inhibit the expression of a6p4 in keratinocytes and can be considered relevant in the control ofkeratinocyte growth and adhesion. In fact, NaHS-induced reduction of p4-integrin expression in the NCTC cell line can explain sulfur-induced cell death as well as sulfur-mediated inhibition of keratinocyte clonal growth and cell adhesion (29) . The NaHS-mediated interference with the Ras/ ERK-1/2 kinase, with the consequent down-regulation of ERKs phosporylation observed after sulfur treatment is responsible for a6p4 inhibition.
According to previous studies, keratinocytes of hyperplastic epidermis express high levels of pERK with the classical nuclear localization, while keratinocytes of normal skin show low pERK levels with a main cytoplasmic localization. By in vivo experiments, we have shown that topic treatment of psoriatic lesions with NaHS water solutions at sulfur concentrations simi lar to that used for balneotherapy, was sufficient to reduce ERK levels in intralesional keratinocytes and, as expected, to reduce their IL-8 production, as well (II, 29).
Purified sulfur has been used as a therapeutic agent to relieve the side effects of radiation therapy in the treatment of cervical cancer. The effects of sulfur on cell proliferation, cell division, and apoptosis in immortalized human skin and oral keratinocytes (HaCaT and IHOKs) and in two oral SCC cell lines (HN4, HNI2) was studied (32) . H 2S induced the morphological and biochemical changes characteristic of apoptosis, as indicated by sub-G I phase accumulation, increase in annexint/Pl" cells, chromatin condensation and DNA fragmentation. The down-regulation of BcI-2, cyclins 0 I, 02, and E, and the up-regulation of p53, CDK inhibitor p21, and p 16 have been proposed as the most relevant molecular mechanism of hydrogen sulfide-mediated anti-proliferative effects (32) . However, several studies have recognized H 2S as a rescuer from hypoxia-induced cell damage (I, 3, 33, 34) , and a similar anti-apoptotic activity may also take place on keratinocytes (28) .
It is remarkable that topical administration ofH 2S promotes dermal wound healing, whereas genetic ablation of CSE attenuates it. Angiogenesis is crucial in the early stages of wound healing and the administration of H 2S to endothelial cells in culture stimulates cell proliferation, migration and tube formation. Moreover, sulfurs stimulate blood vessel growth and branching in vivo (35) . Angiogenetic mediators such as VEGF and angiopoietin-2 play significant roles in the pathophysiology of psoriasis and may even account for the maintenance ofchronic inflammation: thus one could expect unfavorable effects from the topical treatment of psoriatic lesions with sulfurs or sulfur-rich waters due to its intrinsic pro-angiogenic activity. We try a reconciliation of this apparent paradox in the next paragraph.
Fast vs slow H 2S releasing agents
One interesting property of fast H 2S donors as NaHS salts, is the low risk ofsevere secondary effects due to accumulation in unrelated tissues and cells. In fact, at physiological pH values, NaHS rapidly dissociates in Na+ and HS-ions that are rapidly converted into gaseous H 2S. This lipophilic gas is then eliminated by breathing (I). Due to their rapid pharmacokinetics, these sulfur donors tend to induce acute biological effects. On the contrary, slow HSreleasing donors can diffuse and accumulate in other tissues, inducing a chronic HS-mediated stimulation with toxicity and relapse effects. However, it must be said that low HS-releasing compounds, which should be used at lower concentration than NaHS, limit smelling (that can represent a serious obstacle for a topical therapy), are easier to handle and are generally more stable than NaHS or gaseous H 2Senriched solutions. Several disadvantages exist for most of the HS-releasing compounds: the backbone of GYY4137 (36) that remains after H 2S release, the N-benzoylthiobenzamides that acylate biological molecules carrying nucleophilic groups and the S-diclofenac (37) have biological activities unrelated to H 2S release. A new generation of HSreleasing compounds are synthesized (thioglycine and I-thiovaline) with a non-toxic and inert carrier scaffolds (38) .
Several studies have cytoprotective effects of concentrations, whereas exposure of cells to higher (millimolar) HzS concentrations tends to be cytotoxic due to free radical generation, calcium mobilization, glutathione depletion, and induction ofmitochondrial cell death pathways.
Balneotherapy with naturally HzS-rich waters, can be reproduced in part using as surrogate the NaHS-enriched phosphate saline solution. The concentration of HS-and Sz-in spring sulfur water vary considerably, spanning from 0.5 to 20mg/L of equivalent HzS. In general, spa sulfurous water for irrigation, inhalation, bathing and drinking basedtherapies contain more than 1mg/L of HzS (11). However, the actual type(s) and concentration(s) of HzS donors should be determined at each source, and the role played by temperature and additional mineral components of spring water should also be considered. In some studies the net effects of highly concentrated spring water vs tap water have been investigated, excluding that additional benefit of balneotherapy observed in patients with psoriasis and atopic dermatitis are due to the salinity (NaCl in primisi of the liquids (39) .
Mud, gel and other semisolid supports have been generated and used for massage and shampooing treatment. Clinical evaluation of the anti-inflammatory activity of mud-pack has been investigated and general reduction of inflammatory cytokines (IL-6) levels have been reported (40) .
CONCLUSIONS
Balneotherapy is certainly a relaxing and restorative experience -that can be well considered as part of the therapy -which, however, represents a confounding element in the distinction between "pharmacological" and placebo effects. Thus the immediate translation into clinical studies ofthe basic scientific findings on HzS effects cannot be made. It is well known, in fact, that placebo effects are of particular relevance when diseases such as psoriasis and dermatitis are investigated. However, animal studies might be designed for this purpose, for which appropriate models are immediately available. The question is whether or not there is sufficient scientific evidence now supporting the integration of sulfur waters in the therapy of specific skin diseases, when appropriate (Fig. 1) . Given the potential benefits for the patients, the low-intensity caring and the savings in health costs, this question should arise spontaneously. However, despite the basic scientific data on sulfurs, the belief that balneotherapy (including sulfur water therapies) will never reach the level of scientific demonstration of therapeutic efficacy (40) , and should therefore be kept out of the medical field tout court, is generally diffuse. We did not meta-analyze here the available scientific literature in the balneotherapy field, which is, by the way, much broader than currently believed. Instead, we took the most active component of thermal waters (the sulfur ion) revisiting some of its robustly demonstrated biological effects. As a conclusion, we believe that a special research effort could be reasonably dedicated to bring to the same table of discussion what is now known on the cellular effects ofHzS and what has been observed for centuries about the clinical effects of sulfur balneotherapy on some dermatological conditions. No doubt prejudices of various origines) shadow the potential link between the two ends of this line: animal studies, we believe, should now be implemented to close the circle.
